Bill > HB648

This bill requires health insurance providers in New Hampshire to expand coverage for individuals with diabetes, specifically mandating that insurers cover continuous glucose monitoring systems (CGMS) and related supplies for people with Type 2 diabetes or gestational diabetes. The bill requires insurers to cap insulin prescription copayments at $30 for a 30-day supply, eliminate deductibles for glucose monitoring devices, and include at least two types of monitoring devices in their preferred providers or formularies. Importantly, the coverage must be provided without requiring prior authorization, endocrinology referrals, or specific insulin usage patterns. To maintain coverage, patients must participate in follow-up care with their healthcare practitioner every 6 months during the first 18 months of using the glucose monitoring system, and then annually thereafter. The bill applies to individual and group health insurance policies, health service corporations, and health maintenance organizations, ensuring comprehensive coverage across different types of health insurance plans. The legislation aims to improve diabetes management by making glucose monitoring more accessible and affordable for patients, with the bill set to take effect 60 days after its passage.

Business and Industry

https://gc.nh.gov/bill_status/legacy/bs2016/bill_status.aspx?lsr=0120&sy=2025&sortoption=&txtsessionyear=2025&txtbillnumber=HB648